These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 35667465)

  • 1. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.
    Kumar V; Varghese S
    Adv Healthc Mater; 2019 Feb; 8(4):e1801198. PubMed ID: 30516355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy.
    Parlato S; Grisanti G; Sinibaldi G; Peruzzi G; Casciola CM; Gabriele L
    Lab Chip; 2021 Jan; 21(2):234-253. PubMed ID: 33315027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Models for Precision Cancer Immunotherapy.
    Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
    Front Immunol; 2022; 13():770465. PubMed ID: 35450073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer organoids and their applications for precision cancer immunotherapy.
    Guan D; Liu X; Shi Q; He B; Zheng C; Meng X
    World J Surg Oncol; 2023 Oct; 21(1):343. PubMed ID: 37884976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-on-Chip platforms to study tumor evolution and chemosensitivity.
    Dsouza VL; Kuthethur R; Kabekkodu SP; Chakrabarty S
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188717. PubMed ID: 35304293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
    Boucherit N; Gorvel L; Olive D
    Front Immunol; 2020; 11():603640. PubMed ID: 33362787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D cancer models: One step closer to
    Manduca N; Maccafeo E; De Maria R; Sistigu A; Musella M
    Front Immunol; 2023; 14():1175503. PubMed ID: 37114038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy.
    Wang J; Chen C; Wang L; Xie M; Ge X; Wu S; He Y; Mou X; Ye C; Sun Y
    Front Oncol; 2022; 12():872531. PubMed ID: 35449581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic systems for modeling digestive cancer: a review of recent progress.
    Razavi Z; Soltani M; Pazoki-Toroudi H; Dabagh M
    Biomed Phys Eng Express; 2024 Aug; 10(5):. PubMed ID: 39142294
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
    Magré L; Verstegen MMA; Buschow S; van der Laan LJW; Peppelenbosch M; Desai J
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37220953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid Models of Tumor Immunology.
    Yuki K; Cheng N; Nakano M; Kuo CJ
    Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-chip recapitulation of the tumor microenvironment: A decade of progress.
    Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
    Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology.
    Xie H; Appelt JW; Jenkins RW
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tumor Microenvironment: An Introduction to the Development of Microfluidic Devices.
    Kundu B; Caballero D; Abreu CM; Reis RL; Kundu SC
    Adv Exp Med Biol; 2022; 1379():115-138. PubMed ID: 35760990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.